PATH Develops Technology That Protects Hepatitis B Vaccine From Heat and Freeze Damage

Breakthrough formulation methods, recently published in Human Vaccines and Vaccine, help to stabilize hepatitis B vaccine when temperatures rise and fall

SEATTLE, WA -- PATH scientists and collaborators have developed formulation methods that protect hepatitis B vaccine from heat and freeze damage, helping to ensure the potency of hepatitis B vaccine in areas of the world where the cold chain is insufficient. For the full press release, visit the PATH web site.

###
Bill & Melinda Gates Foundation
Guided by the belief that every life has equal value, the Bill & Melinda Gates Foundation works to help all people lead healthy, productive lives. In developing countries, it focuses on improving people’s health and giving them the chance to lift themselves out of hunger and extreme poverty. In the United States, it seeks to ensure that all people—especially those with the fewest resources—have access to the opportunities they need to succeed in school and life. Based in Seattle, Washington, the foundation is led by CEO Jeff Raikes and Co-chair William H. Gates Sr., under the direction of Bill and Melinda Gates and Warren Buffett.

Related Grant

PATH

ONLINE RESOURCES

PATH

PRESS RELEASES

Feb 01, 2012Gates Foundation Invites Public to Explore New Visitor Center Jan 30, 2012Private and Public Partners Unite to Combat 10 Neglected Tropical Diseases by 2020 Jan 26, 2012Foundation Commits $750 Million to Global Fund